Third, the two identified tumor antigen genes, ZNF831 and SYNE1, which have the potential to aid the development of cancer vaccines, should be viewed as hypothesis generating rather than conclusions, because the causal effects of the correlations cannot be determined in the current study. This evidence concerns the gene SYNE1 and cancer.